Despite our efforts to combine data from laboratory and clinical trials, which are indicative of the suppressive or promoting effect of the EPH/ephrin system, we found ephrin-B1 as the only common molecule from the EPH/ephrin axis being studied among bone and soft tissue sarcomas. The gene discussed is EPHA1; the disease is soft tissue sarcoma.